Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CNP520
CNP520
Novartis and Amgen launch new Alzheimer’s study
Endpoints
Thu, 11/2/17 - 10:12 pm
Novartis
Amgen
Alzheimer's disease
CNP520
clinical trials
Novartis to Work With Amgen on Alzheimer’s and Migraine Drugs
Bloomberg
Wed, 09/2/15 - 10:18 am
Novartis
Amgen
migraines
Alzheimer's disease
R&D
CNP520
AMG 334